Researchers complete Gardasil 9 HPV vaccine’s international phase 2/3 trial
The international phase 2/3 clinical trial, which involved Moffitt Cancer Center faculty, demonstrated that Gardasil 9 vaccination can protect against nine HPV types, seven of which cause most
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.